IUOPA,
Women who carry pathogenic or likely-pathogenic variants of ATM or pathogenic mutations in BRCA1/2 or CHEK2*1100delC may not be…
JNCI: Journal of the National Cancer Institute,
Women who carry pathogenic or likely-pathogenic variants of ATM or pathogenic mutations in BRCA1/2 or CHEK2*1100delC may not be…
岸和田市乳腺外科専門医のページ,
BRCA1/2 遺伝子変異例は一側乳がん後の対側乳がん罹患リスクは高いが、初発乳がんに対する放射線治療によりそのリスクは増加しない (文献2020-036)。 "Radiation treatment, ATM, BRCA1/2, and CHEK2*11…